RT @growthrapidly: 🚨 BREAKING: $HIMS just launched injectable and oral testosterone replacement therapies, marking its largest expansion in men's health to date. With nearly 20 million U.S. men affected by low testosterone, Hims is tapping into a massive market opportunity. Another major step in its expansion beyond its core offerings.
在 X 查看 ↗